According to news from the financial industry on January 22, 2025, information from the State Intellectual Property Office shows that Suzhou Jiyinga Biomedical Engineering Co., Ltd. has obtained a project called \”a switch door module and pipetting equipment\” The patent, authorization announcement number CN 222313139 U, application date is April 2024.
The patent abstract shows that the utility model belongs to the technical field of testing equipment and provides a switch door module and pipetting equipment. The switch door module includes a frame, which is connected to the rack of the equipment on which the switch door module is installed. ; Sliding component, which is arranged on the frame, and the sliding component is arranged along the X direction or the vertical direction; Folding door, one end of which is rotationally connected to one side of the frame, and the other end is connected to the sliding component, and the folding door can move along the X direction through the sliding component Or slide back and forth vertically and fold.
Tianyancha data shows that Suzhou Jiyinga Biomedical Engineering Co., Ltd. was established in 2016 and is located in Suzhou City. It is an enterprise mainly engaged in research and experimental development. The registered capital of the enterprise is RMB 90 million, and the paid-in capital is RMB 90 million. Through Tianyancha big data analysis, Suzhou Jiyinga Biomedical Engineering Co., Ltd. has invested in 2 companies, participated in 61 bidding projects, and has 77 pieces of patent information. In addition, the company also has 13 administrative licenses.
This article comes from the financial world
本站内容及图片来自网络,版权归原作者所有,内容仅供读者参考,不承担相关法律责任,如有侵犯请联系我们:609448834